Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team - PubMed (original) (raw)

Clinical Trial

Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team

S F Olsen et al. BJOG. 2000 Mar.

Abstract

Objective: To test the postulated preventive effects of dietary n-3 fatty acids on pre-term delivery, intrauterine growth retardation, and pregnancy induced hypertension.

Design: In six multicentre trials, women with high risk pregnancies were randomly assigned to receive fish oil (Pikasol) or olive oil in identically-looking capsules from around 20 weeks (prophylactic trials) or 33 weeks (therapeutic trials) until delivery.

Setting: Nineteen hospitals in Europe.

Samples: Four prophylactic trials enrolled 232, 280, and 386 women who had experienced previous pre-term delivery, intrauterine growth retardation, or pregnancy induced hypertension respectively, and 579 with twin pregnancies. Two therapeutic trials enrolled 79 women with threatening pre-eclampsia and 63 with suspected intrauterine growth retardation.

Interventions: The fish oil provided 2.7 g and 6.1 g n-3 fatty acids/day in the prophylactic and therapeutic trials, respectively.

Main outcome measures: Preterm delivery, intrauterine growth retardation, pregnancy induced hypertension.

Results: Fish oil reduced recurrence risk of pre-term delivery from 33% to 21% (odds ratio 0.54 (95% CI 0.30 to 0.98)) but did not affect recurrence risks for the other outcomes (OR 1.26; 0.74 to 2.12 and 0.98; 0.63 to 1.53, respectively). In twin pregnancies, the risks for all three outcomes were similar in the two intervention arms (95% CI for the three odds ratios were 0.73 to 1.40, 0.90 to 1.52, and 0.83 to 2.32, respectively). The therapeutic trials detected no significant effects on pre-defined outcomes. In the combined trials, fish oil delayed spontaneous delivery (proportional hazards ratio 1.22; 1.07 to 1.39, P = 0.002).

Conclusions: Fish oil supplementation reduced the recurrence risk of pre-term delivery, but had no effect on pre-term delivery in twin pregnancies. Fish oil had no effect on intrauterine growth retardation and pregnancy induced hypertension, affecting neither recurrence risk nor risk in twin pregnancies.

PubMed Disclaimer

Cited by

Fish Consumption and DHA Supplementation during Pregnancy: Study of Gestational and Neonatal Outcomes.
Gualtieri P, Frank G, Cianci R, Dominici F, Mappa I, Rizzo G, De Santis GL, Bigioni G, Di Renzo L. Gualtieri P, et al. Nutrients. 2024 Sep 10;16(18):3051. doi: 10.3390/nu16183051. Nutrients. 2024. PMID: 39339651 Free PMC article.
Fatty acids and pregnancy-induced hypertension: a Mendelian randomization study.
Ma Z, He W. Ma Z, et al. Lipids Health Dis. 2023 Aug 16;22(1):131. doi: 10.1186/s12944-023-01889-x. Lipids Health Dis. 2023. PMID: 37587460 Free PMC article.
Higher Dietary Intake of Animal Protein Foods in Pregnancy Is Associated with Lower Risk of Adverse Birth Outcomes.
Kamenju P, Madzorera I, Hertzmark E, Urassa W, Fawzi WW. Kamenju P, et al. J Nutr. 2022 Nov;152(11):2546-2554. doi: 10.1093/jn/nxac183. Epub 2022 Aug 18. J Nutr. 2022. PMID: 36774120 Free PMC article.
Effects of n-3 polyunsaturated fatty acid supplementation on pregnancy outcomes: a systematic review and meta-analysis.
Hao Y, Sun X, Wen N, Song D, Li H. Hao Y, et al. Arch Med Sci. 2021 Aug 26;18(4):890-899. doi: 10.5114/aoms/141577. eCollection 2022. Arch Med Sci. 2021. PMID: 35832715 Free PMC article. Review.
Evidence based recommendations for an optimal prenatal supplement for women in the US: vitamins and related nutrients.
Adams JB, Kirby JK, Sorensen JC, Pollard EL, Audhya T. Adams JB, et al. Matern Health Neonatol Perinatol. 2022 Jul 11;8(1):4. doi: 10.1186/s40748-022-00139-9. Matern Health Neonatol Perinatol. 2022. PMID: 35818085 Free PMC article. Review.

Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team - PubMed (original) (raw)